MILWAUKEE — Glaucoma is a common and chronic disease that affects a person's vision. There are several ways of treating glaucoma, but there's an innovative new option for patients that reduces eye ...

The iStent inject was safe and effective for treating multiple types of primary open-angle glaucoma individually and in conjunction with cataract surgery, according to data published in Journal of ...

WILMINGTON, NC (WECT) - A procedure for those with Glaucoma is making it easier to manage the degenerative eye condition on a day-to-day basis. Health officials say glaucoma is the second leading ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio SAN FRANCISCO — Decrease in IOP ...

Camille Maertz has been living with glaucoma for nearly two decades. The disease can lead to blindness, and treating it with the traditional therapy of eye drops about a dozen times a day is often ...

To evaluate the safety, efficacy, and the cost of combined phacoemulsification and single iStent insertion in open angle glaucoma (OAG) at 3-years follow-up. This was a prospective, uncontrolled, ...

The US Food and Drug Administration (FDA) has approved the iStent, the smallest medical implant ever, for use in combination with cataract surgery to treat glaucoma. The US Food and Drug ...

East Columbus (Ohio) Surgery Center completed its first iStent inject series, according to Glaukos Corp. Senior Regional Business Manager Andy Wright. Here's what you should know: 1. Daryl Kaswinkel, ...

While Both iStent and iStent inject Showed Significant IOP and Medication Reduction in Combo-Cataract Procedures at 1 Year Postoperative, iStent inject Achieved Greater Absolute IOP Declines with 93% ...

ALISO VIEJO, Calif., June 25, 2025--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of ...